Podiatrists in St Maries, ID Accepting Medicare

1 Podiatrists found. Showing 1 - 1

Family Foot Center Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 229 S 7th St, St Maries, ID 83861 Phone: 509-924-2600

News Archive

Insurers describe coverage of abortion in states with separate premiums

The Washington Post explores the use of riders on health insurance policies to cover abortion, a proposal that has sparked controversy in the national health overhaul debate. "In North Dakota, where insurers can cover abortions if customers pay a separate premium, the state's largest provider says it sells no abortion policies because no one has asked to buy one," The Post reports.

Protein in mice known as RGS13 suppresses allergic reactions

A protein in mice known as RGS13 suppresses allergic reactions, including the severe, life-threatening allergic reaction known as anaphylaxis, according to scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).

Breastfeeding and better hygiene may protect against peptic ulcer bacterium infection

Young children in developing countries are infected at an early age with the bacterium Helicobacter pylori, which can cause peptic ulcers and stomach cancer. New findings show that childrens´ immune responses help in fighting the bacteria. In addition, breastfeeding and better hygiene appear to protect against infection. The results provide hope for a vaccine, according to research from the Sahlgrenska Academy at the University of Gothenburg, Sweden.

Almac's new North American Headquarters launches schedule I-V controlled capabilities

Packaging, storage and distribution of schedule I-V controlled substances is now a fully functional capability of Almac's new North American Headquarters in Souderton, PA. As the phased transition nears its end, the portfolio of services and capacity offered to customers continues to grow as a result of the $120 million investment.

Manhattan Pharmaceuticals reports preliminary results from AST-915 Phase 1/2 study in essential tremor

Manhattan Pharmaceuticals, Inc. announced preliminary results today from a Phase 1/2 study of AST-915 for the treatment of essential tremor. Data from this single dose study demonstrated that AST-915 was safe and well tolerated and demonstrated a clear effect on tremor power.

Read more Medical News

› Verified 3 days ago